DK0449167T3 - Fremgangsmåde til fremstilling af piroxicam/cyclodextrin-komplekser, de opnåede produkter og deres farmaceutiske præparater - Google Patents

Fremgangsmåde til fremstilling af piroxicam/cyclodextrin-komplekser, de opnåede produkter og deres farmaceutiske præparater

Info

Publication number
DK0449167T3
DK0449167T3 DK91104649.8T DK91104649T DK0449167T3 DK 0449167 T3 DK0449167 T3 DK 0449167T3 DK 91104649 T DK91104649 T DK 91104649T DK 0449167 T3 DK0449167 T3 DK 0449167T3
Authority
DK
Denmark
Prior art keywords
piroxicam
products obtained
preparation
pharmaceutical preparations
cyclodextrin complexes
Prior art date
Application number
DK91104649.8T
Other languages
Danish (da)
English (en)
Inventor
Fabio Carli
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK0449167T3 publication Critical patent/DK0449167T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK91104649.8T 1990-03-27 1991-03-25 Fremgangsmåde til fremstilling af piroxicam/cyclodextrin-komplekser, de opnåede produkter og deres farmaceutiske præparater DK0449167T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19829A IT1241088B (it) 1990-03-27 1990-03-27 Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
DK0449167T3 true DK0449167T3 (da) 1998-03-09

Family

ID=11161628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91104649.8T DK0449167T3 (da) 1990-03-27 1991-03-25 Fremgangsmåde til fremstilling af piroxicam/cyclodextrin-komplekser, de opnåede produkter og deres farmaceutiske præparater

Country Status (24)

Country Link
US (1) US5164380A (it)
EP (1) EP0449167B1 (it)
JP (1) JPH04221314A (it)
KR (1) KR0175934B1 (it)
AT (1) ATE157883T1 (it)
AU (1) AU644417B2 (it)
CA (1) CA2039052C (it)
CZ (1) CZ280164B6 (it)
DE (1) DE69127566T2 (it)
DK (1) DK0449167T3 (it)
ES (1) ES2107430T3 (it)
FI (1) FI102461B (it)
GR (1) GR3025305T3 (it)
HU (1) HU217834B (it)
IE (1) IE910969A1 (it)
IL (1) IL97693A (it)
IT (1) IT1241088B (it)
MA (1) MA22089A1 (it)
NO (1) NO178456C (it)
NZ (1) NZ237583A (it)
PT (1) PT97176B (it)
RU (1) RU2034544C1 (it)
SK (1) SK279171B6 (it)
ZA (1) ZA912282B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
SK288117B6 (sk) * 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
ITMI20012749A1 (it) * 2001-12-21 2003-06-21 Chiesi Farma Spa Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
EP1729813B1 (fr) 2004-04-01 2011-04-06 Pierre Fabre Medicament Complexes d'inclusions comprenant du piroxicam, une cyclodextrine et l'arginine
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
JP5552400B2 (ja) * 2010-09-07 2014-07-16 東亜薬品株式会社 生薬類の苦味・不快味をマスキングした顆粒剤、及び口腔内速崩壊錠
CN102008450B (zh) * 2010-12-10 2013-01-30 杭州艾瑞莎生物医药科技有限公司 一种药物-环糊精纳米颗粒及其制备方法
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
KR102337124B1 (ko) * 2021-05-13 2021-12-10 (주)바이오제닉스 탈모 개선용 복합 파우더 및 이를 포함하는 모발용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
JPS6165805A (ja) * 1984-09-10 1986-04-04 Nippon Ekishiyou Kk 防殺虫フイルムの製造方法
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
US4672061A (en) * 1985-01-28 1987-06-09 Pfizer Inc. Antiinflammatory compositions and methods
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione

Also Published As

Publication number Publication date
RU2034544C1 (ru) 1995-05-10
AU7383891A (en) 1991-10-03
HUT60738A (en) 1992-10-28
ATE157883T1 (de) 1997-09-15
IT9019829A1 (it) 1991-09-27
FI911448A0 (fi) 1991-03-26
ZA912282B (en) 1991-12-24
IE910969A1 (en) 1991-10-09
KR0175934B1 (ko) 1999-03-20
IT1241088B (it) 1993-12-29
NO911216D0 (no) 1991-03-25
EP0449167B1 (en) 1997-09-10
IL97693A0 (en) 1992-06-21
FI911448A (fi) 1991-09-28
NO178456B (no) 1995-12-27
IL97693A (en) 1995-03-30
KR910016333A (ko) 1991-11-05
PT97176A (pt) 1991-11-29
CS9100833A2 (en) 1991-10-15
CA2039052C (en) 2002-07-30
GR3025305T3 (en) 1998-02-27
PT97176B (pt) 1998-07-31
SK279171B6 (sk) 1998-07-08
CZ280164B6 (cs) 1995-11-15
IT9019829A0 (it) 1990-03-27
EP0449167A1 (en) 1991-10-02
DE69127566T2 (de) 1998-02-12
FI102461B1 (fi) 1998-12-15
US5164380A (en) 1992-11-17
NO911216L (no) 1991-09-30
AU644417B2 (en) 1993-12-09
NO178456C (no) 1996-04-03
HU911016D0 (en) 1991-10-28
JPH04221314A (ja) 1992-08-11
NZ237583A (en) 1992-08-26
MA22089A1 (fr) 1991-10-01
DE69127566D1 (de) 1997-10-16
HU217834B (hu) 2000-04-28
FI102461B (fi) 1998-12-15
ES2107430T3 (es) 1997-12-01
CA2039052A1 (en) 1991-09-28

Similar Documents

Publication Publication Date Title
DK0449167T3 (da) Fremgangsmåde til fremstilling af piroxicam/cyclodextrin-komplekser, de opnåede produkter og deres farmaceutiske præparater
DK0511917T3 (da) Glycosylerede prodrugs, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK0555361T3 (da) Pulverformige farvepræparater og fremgangsmåde til fremstilling deraf
CA2162716A1 (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
FI102462B1 (fi) Menetelmä nimesulidin syklodekstriinikompleksin valmistamiseksi
DK0422497T3 (da) Inklusionskomplekser med Silybinin, deres fremstilling af farmaceutiske præparater, der indeholder dem
ES8607016A1 (es) Preparado solido de nifedipina
IT8722631A0 (it) Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che licontengono.
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT8919543A0 (it) Derivati del 1 arilsolfonil pirrolidin 2 tione oppure del 1 arilsolfonil piperidin 2 tione, loro procedimento di preparazione e loro impiego come medicinali.
ES2036504A6 (es) Procedimiento para preparar complejos de ciclodextrina.
IT8247843A0 (it) Medicamenti e prodotti derivati da 3-idrossidodecaidro benz(e) inden-7-one bisostituiti in posizione 6,procedimento di preparazione e intermedi ottenuti
AU665546B2 (en) Conjugates for treating gastrointestinal tumours
IT8920224A0 (it) Complessi con fosfolipidi di derivati neolignanici, loro uso e formulazioni farmaceutiche e cosmetiche che li contengono.
IT8619969A0 (it) Derivati del ferro, procedimento per la loro produzione e relative composizioni farmaceutiche